Moreover, PTEN loss is associated with a high expression of PD-L1, but not in prostate cancer [87], and neoadjuvant hormone therapy could reduce PD-L1 expression in localized prostate cancer [88]. The gene discussed is PTEN; the disease is prostate cancer.